KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $1.94.

  • West Pharmaceutical Services' EPS (Basic) rose 374.33% to $1.94 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.79, marking a year-over-year decrease of 29.37%. This contributed to the annual value of $6.55 for FY2024, which is 1794.55% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported EPS (Basic) of $1.94 as of Q3 2025, which was up 374.33% from $1.82 recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' EPS (Basic) registered a high of $2.53 during Q2 2021, and its lowest value of $1.24 during Q1 2025.
  • Its 5-year average for EPS (Basic) is $1.92, with a median of $1.88 in 2023.
  • In the last 5 years, West Pharmaceutical Services' EPS (Basic) skyrocketed by 11351.35% in 2021 and then tumbled by 3164.56% in 2022.
  • West Pharmaceutical Services' EPS (Basic) (Quarter) stood at $1.94 in 2021, then fell by 28.87% to $1.38 in 2022, then surged by 34.06% to $1.85 in 2023, then decreased by 5.15% to $1.75 in 2024, then rose by 10.55% to $1.94 in 2025.
  • Its EPS (Basic) stands at $1.94 for Q3 2025, versus $1.82 for Q2 2025 and $1.24 for Q1 2025.